On another call http://africanmangosupreme.com/cataflam-pediatrico-novartis/ cataflam pediatrico novartis In the three-year period since the first IDS-TILDA study was conducted in 2010, the prevalence of this disease has nearly doubled in people with Down syndrome - from 15% to just under 30%.